The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -21,713 | -5,330 | -23,747 | -47,924 |
| Share-based compensation | 1,704 | 795 | 1,285 | 3,691 |
| Stock issued for services | 50 | 50 | 100 | 50 |
| Depreciation | 2,523 | 2,546 | 2,325 | 4,708 |
| Bad debt expense | 276 | 385 | - | - |
| Intangibles and other amortization expense | 12 | 11 | 12 | 23 |
| Debt related fees and amortization expense | 1,971 | 1,876 | 1,061 | 3,770 |
| Accretion and other expenses of series a preferred units | 1,613 | 1,881 | 2,034 | 4,311 |
| Loss on asset sales | -2 | 0 | 4 | 0 |
| Gain on debt/liability extinguishment | - | 1,007 | 0 | - |
| Loss on impairment of intangibles | - | 43 | - | - |
| Accounts receivable | 6,558 | -785 | -961 | 444 |
| Inventories | -830 | 7,221 | -7,378 | -12,958 |
| Prepaid expenses | -383 | -97 | 95 | -274 |
| Tax credit sale receivable | 0 | 0 | 0 | -12,300 |
| Other assets | 3,690 | 3,861 | 826 | -150 |
| Accounts payable | 1,155 | 1,705 | 229 | -9,467 |
| Accrued interest expense and fees | 11,799 | 11,306 | 10,104 | 9,380 |
| Other liabilities | -914 | 1,711 | 2,251 | 643 |
| Net cash provided by (used in) operating activities | -10,557 | 5,772 | 3,068 | -5,577 |
| Capital expenditures | 6,548 | 16,561 | 4,091 | 5,350 |
| Grant proceeds for capital expenditures | 1,440 | - | - | - |
| Grant proceeds received for capital expenditures | - | 0 | 0 | 411 |
| Proceeds from sale of fixed assets | 2 | - | - | - |
| Net cash used in investing activities | -5,106 | -16,561 | -4,091 | -4,939 |
| Proceeds from borrowings | 15,984 | 15,680 | 7,927 | 21,319 |
| Repayments of borrowings | 7,877 | 1,375 | 10,318 | 25,411 |
| Payments on series a preferred financing | 0 | 6,070 | 0 | 2,200 |
| Lender debt renewal and waiver fee payments | 0 | 812 | 0 | 495 |
| Payments on finance leases | 0 | 0 | 6 | 162 |
| Proceeds from sales of common stock | 6,588 | 2,588 | 7,527 | 17,960 |
| Proceeds from exercise of stock options | 0 | 0 | 0 | 257 |
| Net cash provided by financing activities | 14,695 | 10,011 | 5,130 | 11,268 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | -53 | 112 | -145 | 7 |
| Net change in cash, cash equivalents, and restricted cash for period | -1,021 | -666 | 3,962 | 759 |
| Cash, cash equivalents, and restricted cash at beginning of period | 7,886 | 8,552 | 3,831 | - |
| Cash, cash equivalents and restricted cash at end of period | 6,865 | 7,886 | 8,552 | - |
AEMETIS, INC (AMTX)
AEMETIS, INC (AMTX)